STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
STAAR Surgical (STAA) Tops Q3 EPS by 10c, Revenues Beat; 'Raises Outlook for Full Year 2018'
October 31, 2018 4:05 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q3 EPS of $0.07, $0.10 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $31.8 million versus the consensus estimate of $29.02 million.
Net Sales of $31.8 Million Up 35% from the Prior Year QuarterICL Sales Up 46% and Units Up 56% from the Prior Year QuarterGross Margin at 75.1% of Sales from 71.8% of Sales in the Prior Year QuarterEarnings per Share of $0.03 versus Earnings per Share of $0.03 in the Prior Year QuarterNon-GAAP Earnings per Share of $0.07 versus Earnings per Share of $0.04 in the Prior Year... More